GLORY was designed to predict metabolites that can be formed in humans by enzymes belonging to the cytochrome P450 (CYP) enzyme family. To do so, GLORY uses a two-pronged approach consisting of the following aspects: the incorporation of site of metabolism (SoM) prediction with FAME 2 and transformation of the molecule into its potential metabolites using a new set of reaction rules developed specifically for GLORY.
SoM prediction is the prediction of metabolically labile atom positions in a molecule. FAME 2, which was developed previously in our research group, is a machine learning-based tool that was developed to predict SoMs for CYP metabolism in humans. The models were developed using the extremely randomized trees algorithm and 2D circular descriptors of atoms and their environments. FAME 2 was shown to have a high level of accuracy, achieving a Matthews correlation coefficient (MCC) of 0.57 and an AUC of 0.91 on an independent test set. For more details on FAME 2, see the FAME 2 publication.
GLORY uses SoM prediction with FAME 2 as an initial step in the prediction of the metabolite structures. Depending on the mode (MaxCoverage or MaxEfficiency), the predicted SoMs are incorporated slightly differently.
The reaction rules were developed based on known CYP-mediated reactions documented in the scientific literature. Hence the reaction rule base is not biased by any particular dataset.
The reactions found in the literature were represented as SMIRKS based on our chemical knowledge. The full list of reaction types and their SMIRKS can be found in the publication.
The predictions made by GLORY are scored and ranked (per input molecule) based on the predicted SoM probabilities of the atoms involved in the reaction and whether the reaction type is common or not.
For more details on the method development and evaluation of GLORY, including the reaction rules and the datasets, please refer to the publication.
Choose which mode you would like to use for metabolite prediction: MaxCoverage or MaxEfficiency. MaxCoverage is the default mode.
Enter SMILES, draw a molecule, or upload a file (.smi or .sdf). The input file may contain up to 1,000 molecules if it is a SMILES file or be up to 40 MB in size (approximately 15,000 molecules) if it is an SDF file. Please note that files larger than a few MB may take some time to upload. Click submit to start the calculation. You will then be forwarded to the result page.
Note that GLORY only makes predictions for input molecules containing at least 3 heavy atoms and does not predict any metabolites containing fewer than 3 heavy atoms. Note also that GLORY can not make predictions for molecules containing any atoms other than the following: C, N, S, O, H, F, Cl, Br, I, and P. This is the case because FAME 3 can not make predictions for molecules containing atoms that are not included in this list.
Each SMILES and/or SDF entry should represent a single-component molecule. No predictions are made for multi-component molecules.
All molecules should be neutral and already have explicit hydrogens added. If there are missing hydrogens, the software will attempt to automatically add correct hydrogens before making predictions.
On the result page, you will be able to download the predictions as an .sdf file. In the .sdf file, the structures of the predicted metabolites are provided along with the following information for each predicted metabolite:
If the same metabolite was predicted via multiple reaction rules, the information corresponding to the version with the highest score is reported.
If the input contains fewer than 25 molecules, the individual predictions for each input molecule can be viewed. A visualization of each input molecule and its predicted metabolites is provided, as well as a visual representation of the FAME 2 site of metabolism predictions.
If no predictions could be made for a particular input molecule, a corresponding error message will be displayed.
de Bruyn Kops, C.; Stork, C.; Šícho, M.; Kochev, N.; Svozil, D.; Jeliazkova, N.; Kirchmair, J. GLORY: Generator of the Structures of Likely Cytochrome P450 Metabolites Based on Predicted Sites of Metabolism. Front. Chem. 2019, 7:402.
doi: 10.3389/fchem.2019.00402
Stork, C.; Embruch, G.; Šícho, M.; de Bruyn Kops, C.; Chen, Y.;
Svozil, D.; Kirchmair, J. NERDD: a web portal providing access to in
silico tools for drug discovery. Bioinformatics
2020.
doi: 10.1093/bioinformatics/btz695
To report a problem or give feedback, please go to the Feedback & Support page or contact us directly: